Compare CNVS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNVS | ECOR |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 49.1M |
| IPO Year | 2016 | 2018 |
| Metric | CNVS | ECOR |
|---|---|---|
| Price | $2.47 | $6.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 145.8K | 52.1K |
| Earning Date | 02-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $78,181,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | $84.42 | $30.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 59.13 | 27.20 |
| 52 Week Low | $1.77 | $4.16 |
| 52 Week High | $7.39 | $8.30 |
| Indicator | CNVS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 56.63 |
| Support Level | $2.31 | $6.57 |
| Resistance Level | $2.56 | $7.50 |
| Average True Range (ATR) | 0.14 | 0.44 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 52.81 | 73.95 |
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.